Premium
Patterns of treatment for early stage breast cancers at the M. D. Anderson Cancer Center from 1997 to 2004
Author(s) -
Shen Yu,
Dong Wenli,
Feig Barry W.,
Ravdin Peter,
Theriault Richard L.,
Giordano Sharon H.
Publication year - 2009
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.24271
Subject(s) - medicine , breast cancer , tamoxifen , anthracycline , mastectomy , stage (stratigraphy) , cancer , oncology , sentinel lymph node , chemotherapy , anastrozole , clinical trial , adjuvant therapy , gynecology , paleontology , biology
Abstract BACKGROUND: The objectives of this study were to examine the patterns of use for adjuvant therapy and the changes in surgical practice for patients with early stage breast cancer and to describe how recent large clinical trial results impacted the patterns of care at The University of Texas M. D. Anderson Cancer Center (MDACC). METHODS: The study included 5486 women who were diagnosed with stage I through IIIA breast cancer between 1997 and 2004 and received their treatment at MDACC. A chi‐square trend test and multivariate logistic regression model were used to assess changes in treatment patterns over time. RESULTS: Among lymph node‐positive patients, the use of anthracycline plus taxane chemotherapy increased from 17% in 1997 to 81% in 2004 ( P < .001). Meanwhile, the use of anthracyclines without taxanes dropped from 76% to 20% ( P < .001) between 1997 and 2000. For postmenopausal patients who received endocrine therapy, the use of tamoxifen was replaced increasingly by the use of aromatase inhibitors (from 100% on tamoxifen in 1997 to 14% in 2004; P < .001). The percentage of women who underwent initial sentinel lymph node biopsy increased significantly during the period from 1997 to 2004 (from 1.8% to 69.7%, respectively, among patients who underwent mastectomy; and from 18.1% to 87.1%, respectively, among patients who underwent breast‐conserving surgery; P < .001). CONCLUSIONS: The results from this study suggested that key findings from adjuvant therapy and surgical procedures from large clinical trials often prompt immediate changes in the patient care practices of research hospitals like MDACC. Cancer 2009. © 2009 American Cancer Society.